5 completed, 1 unknown. 6 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 5, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Yersinia Infections: new trials by email Literature Review of Yersinia Infections trials Research Report on Yersinia Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age rF1V-1018, rF1V vaccine - Plague, Pneumonic, Plague | Phase 2 | Completed | Dynavax Technologies Corporation | 200 | 2022-08-09 | 2025-07-29 |
| Immunogenicity and Safety of Subunit Vaccine of Plague Vaccine With Two Immunization Regimens plague vaccine(F1+rV) - Plague | Phase 2 | Unknown | Jiangsu Province Centers for Disease Control and Prevention | 720 | 2020-05-08 | 2022-04-15 |
| Immunogenicity and Safety of Subunit Plague Vaccine Plague vaccine - Plague | Phase 2 | Completed | Jiangsu Province Centers for Disease Control and Prevention | 240 | 2014-10-01 | 2015-11-04 |
| A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans ciprofloxacin, doxyxcycline - Plague | Phase 2 | Completed | Centers for Disease Control and Prevention | 5 | 2010-12-01 | 2026-06-03 |
| Randomized Single-Blinded Study to Evaluate Safety and Immunogenicity of Recombinant Plague Vaccine With and Without Adjuvant rF1V vaccine (with Adjuvant), rF1V vaccine (without Adjuvant) - Plague Vaccine | Phase 2 | Completed | DynPort Vaccine Company LLC, A GDIT Company | 402 | 2010-07-01 | 2020-07-30 |
| Treatment and Diagnosis of Plague gentamicin, streptomycin - Plague | Phase 2 / Phase 3 | Completed | Centers for Disease Control and Prevention | 114 | 2004-08-01 | 2009-02-26 |
Plague (6) · Vaccine-Preventable Diseases (1)
Bacterial Infections (6) · Bacterial Infections and Mycoses (6) · Enterobacteriaceae Infections (6) · Gram-Negative Bacterial Infections (6) · Infections (6) · Vector Borne Diseases (6)
Adjuvants, Pharmaceutic (1) · Ciprofloxacin (1) · Gentamicins (1) · Plague Vaccine (1) · Streptomycin (1)
Centers for Disease Control and Prevention (2) · Jiangsu Province Centers for Disease Control and Prevention (2) · DynPort Vaccine Company LLC, A GDIT Company (1) · Dynavax Technologies Corporation (1)
China (2) · United States (2) · Madagascar (1) · Uganda (1)
Edward Mbidde, MD (1) · Fengcai Zhu, Master (1) · George Saviolakis, MD (1) · Issa Makumbi, MD (1) · Kevin Griffith, MD, MPH (1) · Kevin S. Griffith, MD, MPH (1) · Martin Schriefer, PhD (1) · Yuemei Hu, Bachelor (1)